Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 796 AL 810

Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease

Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.

CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome

Dohl J, Treadwell Z, Norris C, Head E.

Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.

Resistance and resilience to Alzheimer's disease in Down syndrome

Boyle R, Koops EA, Ances B, Andrews EJ, Arenaza-Urquijo EM, Bejanin A, Brickman AM, Buckley RF, Clas GS, Costello E, Coughlan GT, Conley AC, Deng F, de Paula Faria D, Edwards N, Flores-Aguilar L, Fortea J, Ghazi Saidi L, Head E, Hom CL, Koenig K, Lao P, Lengyel I, Li YJ, Loi S, Loughrey D, McGlinchey E, Newhouse P, Pertierra L, Prokopiou PC, Qi Q, de Paula França Resende E, Russell J, Scanlon CE, Schneider C, Schultz SA, Seto M, Shaka S, Soldan A, Vaqué Alcázar L, Weng Y, Wilson JE, Zaman SH, Zsadányi SE, Hartley S.

Alzheimers Dement. 2025 Apr;21(4):e70151. doi: 10.1002/alz.70151.

Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review

Diamandis N, van den Anker JN, Denisova K.

Transl Psychiatry. 2025 Nov 17;15(1):475. doi: 10.1038/s41398-025-03655-2.

Determining the Role of Sex and APOE4 status on Psychosis in Alzheimer's Disease

Fan J, Churchill N, Fadhel A, Fornazzari LR, De Luca V, Ismail Z, Munoz DG, Schweizer TA, Fischer CE; Alzheimer’s Disease Neuroimaging Initiative.

J Geriatr Psychiatry Neurol. 2025 Jul;38(4):235-240. doi: 10.1177/08919887241313225. Epub 2025 Mar 24.

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS.

Alzheimers Dement. 2025 Jun;21(6):e70258. doi: 10.1002/alz.70258.

The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer's Disease

Muñoz de León-López CA, Navarro-Lobato I, Khan ZU.

Biomolecules. 2025 Jun 20;15(7):910. doi: 10.3390/biom15070910.

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies

Smoller C, Schiller E, Yamashita K, Silverglate BD, Grossberg GT.

Drugs. 2025 Nov;85(11):1391-1411. doi: 10.1007/s40265-025-02227-4. Epub 2025 Sep 6.

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease

Zhong K, Cummings J.

Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.

Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment

Lee HH, Chinnameyyappan A, Feldman OJ, Marotta G, Survilla K, Lanctôt KL.

Curr Top Behav Neurosci. 2025;69:245-273. doi: 10.1007/7854_2024_566.

A US-based practitioner's guide to diagnosis, evaluation, and evidence-based treatment of agitation in Alzheimer's dementia - recommendations of an expert, multispecialty advisory panel

Grossberg GT, Sanford A, Montano CB, Porsteinsson AP, Scanland S, Worz C, McMillian S, Atri A.

Postgrad Med. 2025 Aug;137(6):469-485. doi: 10.1080/00325481.2025.2517535. Epub 2025 Jun 17.

Stem cell-based therapeutic strategies for down syndrome and Alzheimer's disease

Hamadelseed O, Skutella T.

Stem Cell Res Ther. 2025 Aug 5;16(1):420. doi: 10.1186/s13287-025-04556-3.

Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sites

Ptomey L, Hom C, Wilkins H, Doran E, Wright ST, Hoang D, Delehoy B, Lott IT, Perales-Puchalt J, Helsel B, Burns J, Grill JD, Head E.

Alzheimers Dement. 2025 Aug;21(8):e70612. doi: 10.1002/alz.70612.

Neuropathology of trisomy 21 mosaicism in a case with early-onset dementia

Ngo PT, Pascual JR, Wright S, Williams CK, Magaki S, Yong WH, Vinters HV, Ringman JM, Head E.

Alzheimers Dement. 2025 Jan;21(1):e14394. doi: 10.1002/alz.14394. Epub 2024 Dec 10.

Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease

Ogg J, Postupna N, Gibbons LE, Ariza J, Xiao M, Fonseca LM, Jayadev S, Keene CD, Bird TD, Latimer CS.

Acta Neuropathol. 2025 Sep 4;150(1):24. doi: 10.1007/s00401-025-02931-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias